HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY

被引：0
|
作者：
VANDOORN, PA
BRAND, A
STRENGERS, PFW
MEULSTEE, J
VERMEULEN, M
机构：
[1] STATE UNIV LEIDEN HOSP,DEPT IMMUNOHEMATOL,2333 AA LEIDEN,NETHERLANDS
[2] STATE UNIV LEIDEN HOSP,BLOODBANK,2333 AA LEIDEN,NETHERLANDS
[3] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS
来源：
NEUROLOGY | 1990年 / 40卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：209 / 212
页数：4
相关论文
共 50 条
  • [21] Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
    S. R. M. Bus
    L. Zambreanu
    A. Abbas
    Y. A. Rajabally
    R. D. M. Hadden
    R. J. de Haan
    C. A. J. M. de Borgie
    M. P. Lunn
    I. N. van Schaik
    F. Eftimov
    Trials, 22
  • [22] Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone
    Lopate, G
    Pestronk, A
    Al-Lozi, M
    ARCHIVES OF NEUROLOGY, 2005, 62 (02) : 249 - 254
  • [23] High-dose immunoglobulin therapy in sporadic inclusion body myositis:: a double-blind, placebo-controlled study
    Walter, MC
    Lochmüller, H
    Toepfer, M
    Schlotter, B
    Reilich, P
    Schröder, M
    Müller-Felber, W
    Pongratz, D
    JOURNAL OF NEUROLOGY, 2000, 247 (01) : 22 - 28
  • [24] High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study
    M. C. Walter
    H. Lochmüller
    M. Toepfer
    B. Schlotter
    P. Reilich
    M. Schröder
    W. Müller-Felber
    D. Pongratz
    Journal of Neurology, 2000, 247 : 22 - 28
  • [25] Intravenous Immunoglobulin for Treatment of Demyelinating Polyneuropathy in Patients with Diabetes Mellitus: A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial
    Breiner, Ari
    Tapia, Carolina Barnett
    Lovblom, Leif Erik
    Perkins, Bruce
    Katzberg, Hans
    Bril, Vera
    NEUROLOGY, 2019, 92 (15)
  • [26] High-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments
    Wee, Tze Chao
    Tan, Yeow Leng
    PAIN MEDICINE, 2020, 21 (10) : 2603 - 2604
  • [27] MAINTENANCE TREATMENT FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIPD) WITH SUBCUTANEOUS IMMUNOGLOBULIN IGPRO20: THE MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PATH TRIAL
    Pinter, Lauria G.
    van Schaik, I
    Bril, V
    van Geloven, N.
    Hartung, H.
    Lewis, R.
    Sobue, G.
    Lawo, J.
    Mieke, O.
    Durn, B.
    Cornblath, D.
    Merkies, I
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 : S26 - S26
  • [28] Treatment of chronic rhinosinusitis with high-dose oral terbinafine: A double blind, placebo-controlled study
    Kennedy, DW
    Kuhn, FA
    Hamilos, DL
    Zinreich, SJ
    Butler, D
    Warsi, G
    Pfister, PJ
    Tavakkol, A
    LARYNGOSCOPE, 2005, 115 (10): : 1793 - 1799
  • [29] CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY OF CHILDHOOD - TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
    VEDANARAYANAN, VV
    KANDT, RS
    LEWIS, DV
    DELONG, GR
    NEUROLOGY, 1991, 41 (06) : 828 - 830
  • [30] Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma
    Niggemann, B
    Leupold, W
    Grübl, A
    Hardt, HVD
    Schuster, A
    Schuster, R
    Berg, AV
    Eibl, MM
    Wahn, U
    CLINICAL AND EXPERIMENTAL ALLERGY, 1998, 28 (02): : 205 - 210
12345